Caladrius Bio (CLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLBS | AMGN | GILD | VRTX | BIIB |
| Company | Caladrius Bio | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 9.7200 | 335.15 | 83.26 | 474.36 | 200.01 |
| High | 9.7500 | 338.97 | 83.99 | 474.93 | 200.37 |
| Low | 5.7300 | 334.27 | 82.75 | 463.81 | 196.96 |
| Last | 6.3960 | 337.38 | 83.94 | 464.92 | 199.36 |
| Change | -1.2585 | +1.43 | +0.04 | -12.98 | -2.08 |
| % Change | -16.44% | +0.43% | +0.05% | -2.72% | -1.03% |
| Volume | 1,796,440 | 4,068,200 | 24,925,900 | 2,238,700 | 3,833,500 |
| 20-Day Average Volume | 1,469,975 | 1,855,500 | 7,644,690 | 1,043,350 | 980,680 |
| Previous Close | 7.6545 | 335.95 | 83.90 | 477.90 | 201.44 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5057 | 330.23 | 80.47 | 479.12 | 201.40 |
| 20-Day Raw Stochastic | 16.57% | 91.90% | 89.42% | 10.69% | 49.20% |
| 20-Day Relative Strength | 32.97% | 58.76% | 71.95% | 43.24% | 42.93% |
| Weighted Alpha | -64.50 | +27.84 | +18.32 | +28.48 | -22.73 |
| Today's Opinion | 88% Sell | 100% Buy | 88% Buy | 24% Buy | 100% Sell |
| Previous Opinion | 88% Sell | 96% Buy | 88% Buy | 40% Buy | 100% Sell |
| Last Month's Opinion | 72% Sell | 88% Buy | 56% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.39% since 09/07/22 | +1.48% since 09/13/24 | +1.36% since 09/13/24 | -4.21% since 09/13/24 | +1.91% since 09/13/24 |
| Low | 0.3820 on 09/14/22 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 463.81 on 09/20/24 | 194.75 on 09/16/24 |
| High | 0.6500 on 09/14/22 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 490.15 on 09/16/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | -20.63% since 08/12/22 | +2.69% since 08/20/24 | +12.29% since 08/20/24 | -4.61% since 08/20/24 | -2.98% since 08/20/24 |
| Low | 0.3820 on 09/14/22 | 319.00 on 09/06/24 | 74.80 on 08/21/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 0.6500 on 09/14/22 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | -14.72% since 06/14/22 | +8.87% since 06/20/24 | +22.56% since 06/20/24 | -1.37% since 06/20/24 | -11.62% since 06/20/24 |
| Low | 0.3820 on 09/14/22 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 0.6500 on 09/14/22 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -34.40% since 03/14/22 | +23.56% since 03/20/24 | +13.46% since 03/20/24 | +12.81% since 03/20/24 | -8.61% since 03/20/24 |
| Low | 0.3820 on 09/14/22 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.7960 on 03/24/22 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 25,833 | 180,215,344 | 104,527,072 | 123,323,528 | 29,329,060 |
| Shares Outstanding, K | 60,583 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -27,470,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | -6,630,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 0.91 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 08/04/22 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 11/03/22 | 10/29/24 | 11/05/24 | 11/04/24 | 11/13/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.90 | 17.85 | 0.00 | 12.15 |